483
Corden Pharma Colorado, Inc.FDA 483 - Corden Pharma Colorado, Inc. - June 28, 2013
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Cordon Pharma Colorado, Inc. in Boulder, CO, an API manufacturer, revealed significant deficiencies in quality control, facility maintenance, and adherence to internal procedures. Observations included a lack of thorough investigation into out-of-specification incidents, unsanitary conditions in the raw material sampling room, and failures to follow incident reporting and investigation protocols.
Open in Dashboard
ID · f4c04a32-b1f1-46fe-9b43-fe35ef8901ac